Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
PLoS One ; 10(3): e0117954, 2015.
Article in English | MEDLINE | ID: mdl-25785999

ABSTRACT

Aging is defined as the accumulation of progressive organ dysfunction. Controlling the rate of aging by clarifying the complex pathways has a significant clinical importance. Nowadays, sirtuins have become famous molecules for slowing aging and decreasing age-related disorders. In the present study, we analyzed the SIRT1 gene polymorphisms (rs7895833 A>G, rs7069102 C>G and rs2273773 C>T) and its relation with levels of SIRT1, eNOS, PON-1, cholesterol, TAS, TOS, and OSI to demonstrate the association between genetic variation in SIRT1 and phenotype at different ages in humans. We observed a significant increase in the SIRT1 level in older people and found a significant positive correlation between SIRT1 level and age in the overall studied population. The oldest people carrying AG genotypes for rs7895833 have the highest SIRT1 level suggesting an association between rs7895833 SNP and lifespan longevity. Older people have lower PON-1 levels than those of adults and children which may explain the high levels of SIRT1 protein as a compensatory mechanism for oxidative stress in the elderly. The eNOS protein level was significantly decreased in older people as compared to adults. There was no significant difference in the eNOS level between older people and children. The current study is the first to demonstrate age-related changes in SIRT1 levels in humans and it is important for a much better molecular understanding of the role of the longevity gene SIRT1 and its protein product in aging. It is also the first study presenting the association between SIRT1 expression in older people and rs7895833 in SIRT1 gene.


Subject(s)
Gene Expression Regulation, Enzymologic/physiology , Longevity/physiology , Oxidative Stress/physiology , Polymorphism, Single Nucleotide , Sirtuin 1 , Adult , Aged , Aged, 80 and over , Aryldialkylphosphatase/biosynthesis , Aryldialkylphosphatase/genetics , Child , Child, Preschool , Female , Humans , Male , Middle Aged , Nitric Oxide Synthase Type III/biosynthesis , Nitric Oxide Synthase Type III/genetics , Sirtuin 1/biosynthesis , Sirtuin 1/genetics
2.
Clin Exp Pharmacol Physiol ; 42(4): 321-30, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25582759

ABSTRACT

Statins are 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and are used to reduce the risk of coronary artery disease (CAD) due to their pleiotropic effects. Recently, greater focus has been placed on the role of sirtuin 1 (SIRT1) in cardiovascular disease research. However, insufficient data exist on the relationships between statins, SIRT1 protein levels, and SIRT1 gene variants. In the present study, we investigated the effects of statins, atorvastatin and rosuvastatin, in CAD patients by analysing the associations between SIRT1 gene variants, rs7069102C>G and rs2273773C>T, and SIRT1/endothelial nitric oxide (eNOS) expression, as well as total antioxidant and oxidant status, and the oxidative stress index. SIRT1 expression was significantly higher, and eNOS expression was significantly lower in CAD patients when compared with controls. Statin treatment reduced SIRT1 expression and increased eNOS expression, similar to the levels found in the control population, independent from the studied SIRT1 gene variants. Oxidative stress parameters were significantly increased in CAD patients, and were decreased by statin treatment, demonstrating the antioxidative effects of statins on atherosclerosis. These results indicate that statin treatment could produce its protective effect on cardiovascular disease through the inhibition of SIRT1 expression. This is the first study reporting on the effect of statins, specifically atorvastatin and rosuvastatin, on SIRT1 expression in CAD patients.


Subject(s)
Antioxidants/therapeutic use , Atorvastatin/therapeutic use , Coronary Artery Disease/drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Nitric Oxide Synthase Type III/metabolism , Polymorphism, Single Nucleotide , Rosuvastatin Calcium/therapeutic use , Sirtuin 1/genetics , Case-Control Studies , Coronary Artery Disease/diagnosis , Coronary Artery Disease/enzymology , Coronary Artery Disease/genetics , Female , Gene Frequency , Genotype , Humans , Male , Middle Aged , Oxidative Stress/drug effects , Phenotype , Sirtuin 1/metabolism , Treatment Outcome
3.
Eur J Pediatr ; 174(4): 473-9, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25233986

ABSTRACT

UNLABELLED: Obesity is a multifactorial disorder resulting from the interaction between genetic, psychological, physical, environmental, and socioeconomic factors. SIRT1 gene has important effects on the regulation of adiponectin, caloric restriction, insulin sensitivity, coronary atherosclerosis, and cardiovascular diseases. The aim of this study was to investigate the association between childhood obesity and SIRT1 gene polymorphisms regarding rs7895833 A > G in the promoter region, rs7069102 C > G in intron 4, and rs2273773 C > T in exon 5 using PCR-CTPP method in 120 obese and 120 normal weight children. In this study, BMI, systolic and diastolic blood pressure, LDL cholesterol, triglyceride, and insulin levels were significantly higher and HDL-cholesterol levels were significantly lower in obese children compared to normal weight children. For rs7895833 A > G, the rate of having AG genotype and G allele was significantly higher in obese children compared to non-obese group (p < 0.001). The risk for obesity was increased by 1.9 times in G allele carriers; therefore, A allele may be protective against obesity. Both study groups had CT heterozygote genotype for rs2273773 C > T. There was no significant difference for rs7069102 C > G gene polymorphism between groups. CONCLUSION: This is the first study reporting an association between SIRT1 gene polymorphisms and obesity in children.


Subject(s)
Genetic Predisposition to Disease , Pediatric Obesity/genetics , Sirtuin 1/genetics , Alleles , Blood Pressure , Body Mass Index , Child , Female , Gene Frequency , Genotype , Humans , Insulin/blood , Lipids/blood , Male , Polymerase Chain Reaction , Polymorphism, Genetic , Risk Factors , Turkey
4.
Br J Nutr ; 113(1): 45-55, 2015 Jan 14.
Article in English | MEDLINE | ID: mdl-25400158

ABSTRACT

To date, no structural study has been carried out on the effects of vitamin A deficiency (VAD) on hippocampal macromolecules. Therefore, in the present study, the effect of dietary VAD on the structure, content and function of rat hippocampal molecules was investigated using Fourier transform IF spectroscopy. Male Wistar rats were randomly divided into three groups: an experimental group maintained on a vitamin A-deficient liquid diet (VAD, n 7); a control group maintained on a vitamin A-supplemented liquid diet (CON, n 9); a pure control group maintained on standard solid laboratory chow (PC, n 7). The PC group was included in the study to ensure that the usage of liquid diet did not influence the outcomes of VAD. Both the CON and PC groups were successfully discriminated from the VAD group by principal component analysis and hierarchical cluster analysis. The spectral analysis indicated a significant decrease in the contents of saturated and unsaturated lipids, cholesteryl esters, TAG and nucleic acids in the VAD group when compared with the CON group (P≤ 0·05). In addition, a significant decrease in membrane fluidity and a significant increase in lipid order (e.g. acyl chain flexibility) were observed in the VAD group (P≤ 0·001). The results of the artificial neural network analysis revealed a significant decrease in the α-helix structure content and a significant increase in the turn and random coil structure contents, indicating protein denaturation, in the VAD group when compared with the CON and PC groups (P≤ 0·05). Dietary exclusion of vitamin A for 3 months apparently had an adverse impact on compositional, structural and dynamical parameters. These changes can be due to increased oxidative stress, confirming the antioxidant protection provided by vitamin A when used as a dietary supplement at low-to-moderate doses.


Subject(s)
Hippocampus/pathology , Vitamin A Deficiency/pathology , Animals , Cluster Analysis , Diet , Dose-Response Relationship, Drug , Hippocampus/drug effects , Hippocampus/metabolism , Male , Oxidative Stress/drug effects , Principal Component Analysis , Rats , Rats, Wistar , Spectroscopy, Fourier Transform Infrared , Vitamin A/pharmacology
5.
PLoS One ; 9(2): e90428, 2014.
Article in English | MEDLINE | ID: mdl-24587358

ABSTRACT

Cardiovascular disease (CVD), the leading cause of death worldwide, is related to gene-environment interactions due to epigenetic factors. SIRT1 protein and its downstream pathways are critical for both normal homeostasis and protection from CVD-induced defects. The aim of this study was to investigate the association between SIRT1 single nucleotide polymorphisms (SNPs) (rs7895833 A>G in the promoter region, rs7069102 C>G in intron 4 and rs2273773 C>T in exon 5 silent mutation) and SIRT1 and eNOS (endothelial nitric oxide synthase) protein expression as well as total antioxidant status (TAS), total oxidant status (TOS) and oxidative stress index (OSI) in CVD patients as compared to controls. The frequencies of mutant genotypes and alleles for rs7069102 and rs2273773 were significantly higher in patients with CVD compared to control group. The risk for CVD was increased by 2.4 times for rs7069102 and 1.9 times for rs2273773 in carriers of mutant allele compared with carriers of wild-type allele pointing the protective role of C allele for both SNPs against CVD. For rs7895833, there was no significant difference in genotype and allele distributions between groups. SIRT1 protein, TAS, TOS and OSI levels significantly increased in patients as compared to control group. In contrast, level of eNOS protein was considerably low in the CVD patients. An increase in the SIRT1 expression in the CVD patients carrying mutant genotype for rs7069102 and heterozygote genotype for all three SNPs was observed. This is the first study reporting an association between SIRT1 gene polymorphisms and the levels of SIRT1 and eNOS expressions as well as TAS, TOS and OSI.


Subject(s)
Coronary Artery Disease/genetics , Genetic Predisposition to Disease , Nitric Oxide Synthase Type III/genetics , Polymorphism, Single Nucleotide , Sirtuin 1/genetics , Aged , Alleles , Antioxidants/metabolism , Case-Control Studies , Coronary Artery Disease/metabolism , Coronary Artery Disease/pathology , Exons , Female , Gene-Environment Interaction , Humans , Introns , Male , Middle Aged , Oxidative Stress , Promoter Regions, Genetic
6.
Dev Neurobiol ; 74(5): 498-513, 2014 May.
Article in English | MEDLINE | ID: mdl-24302592

ABSTRACT

Ethanol is known as a potent teratogen having adverse effects on brain and behavior. However, some of the behavioral deficits caused by fetal alcohol exposure and well expressed in juveniles ameliorate with maturation may suggest some kind of functional recovery occurring during postnatal development. The aim of this study was to reexamine age-dependent behavioral impairments in fetal-alcohol rats and to investigate the changes in neurogenesis and gross morphology of the hippocampus during a protracted postnatal period searching for developmental deficits and/or delays that would correlate with behavioral impairments in juveniles and for potential compensatory processes responsible for their amelioration in adults. Ethanol was delivered to the pregnant dams by intragastric intubation throughout 7-21 gestation days at daily dose of 6 g/kg. Isocaloric intubation and intact control groups were included. Locomotor activity, anxiety, and spatial learning tasks were applied to juvenile and young-adult rats from all groups. Unbiased stereological estimates of hippocampal volumes, the total number of pyramidal and granular cells, and double cortin expressing neurons were carried out for postnatal days (PDs) PD1, PD10, PD30, and PD60. Alcohol insult during second trimester equivalent caused significant deficits in the spatial learning in juvenile rats; however, its effect on hippocampal morphology was limited to a marginally lower number of granular cells in dentate gyrus (DG) on PD30. Thus, initial behavioral deficits and the following functional recovery in fetal-alcohol subjects may be due to more subtle plastic changes within the hippocampal formation but also in other structures of the extended hippocampal circuit. Further investigation is required.


Subject(s)
Behavior, Animal/physiology , Ethanol/toxicity , Fetal Alcohol Spectrum Disorders/pathology , Fetal Alcohol Spectrum Disorders/physiopathology , Hippocampus/pathology , Hippocampus/physiopathology , Prenatal Exposure Delayed Effects , Animals , Behavior, Animal/drug effects , Cell Count , Central Nervous System Depressants/adverse effects , Doublecortin Domain Proteins , Doublecortin Protein , Exploratory Behavior/drug effects , Exploratory Behavior/physiology , Female , Hippocampus/drug effects , Hippocampus/growth & development , Male , Maze Learning/drug effects , Maze Learning/physiology , Microtubule-Associated Proteins/metabolism , Neurogenesis/drug effects , Neurogenesis/physiology , Neurons/drug effects , Neurons/pathology , Neurons/physiology , Neuropeptides/metabolism , Organ Size , Pregnancy , Pyramidal Cells/drug effects , Pyramidal Cells/growth & development , Pyramidal Cells/pathology , Pyramidal Cells/physiology , Rats, Wistar
7.
Front Nutr ; 1: 28, 2014.
Article in English | MEDLINE | ID: mdl-25988128

ABSTRACT

Cisplatin is one of the effective chemotherapeutics in the treatment of several types of cancers. However, in addition to the efforts against to its toxicity, the amelioration of cisplatin sensitivity is an important point in treatment of cervical cancer. To do so, additional substances such as epigallocatechin gallate (EGCG), a polyphenol in green tea, have been used in combination with chemotherapeutics. We aimed to investigate the possible molecular pathways to potentiate cervical cancer cell (HeLa) growth inhibition by combination therapy of cisplatin and EGCG. HeLa cells were treated with EGCG (25 µM), cisplatin (250 nM), and their combination for 24 h. Cell viability was determined by MTS Assay. We analyzed the expressions of NF-κB p65, COX-2, Nrf2, HO-1, p-mTOR, p-p70S6K1, p-4E-BP1, and p-Akt by Western blot analysis. Herein, we have demonstrated that EGCG works synergistic with cisplatin in inhibiting growth of cervical cancer cells. EGCG improved efficacy of cisplatin treatment in HeLa cells by regulating NFκB p65, COX-2, p-Akt, and p-mTOR pathways, whereas it increased the expression levels of Nrf2/HO-1 in combined therapy. Our observations revealed that EGCG increases the sensitization of cisplatin to cervical cancer cells by inhibiting cell survival and inducing apoptosis.

8.
Int J Dev Neurosci ; 33: 106-14, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24365761

ABSTRACT

Ethanol is known as a potent teratogen responsible for the fetal alcohol syndrome characterized by cognitive deficits especially pronounced in juveniles but ameliorating in adults. Since the mechanisms of these deficits and following partial recovery are not fully elucidated, the aim of the present study was to investigate the process of synaptogenesis in the hippocampus over the first two months of life in control and fetal-alcohol rats. Ethanol was delivered to the pregnant dams by intragastric intubation throughout 7-21 gestation days at the daily dose of 6g/kg generating a mean blood alcohol level of 246.6±40.9mg/dl on gestation day 20. The spine densities as well as the expression of pre- and postsynaptic proteins, synaptophysin (SYP) and PSD-95 protein, were evaluated for three distinct hippocampal regions: CA1, CA2+3, and DG and four postnatal days: PD1, PD10, PD30 and PD60, independently. Our results confirmed an intensive synaptogenesis within the brain spurt period (first 10 postnatal days), however, the temporal pattern of changes in the SYP and PSD-95 expression was different. The ethanol exposure during half of the 1st and the whole 2nd human trimester equivalent resulted in an overall trend toward lower values of synaptic indices at PD1 with a fast recovery from these deficits observed already at PD10. At PD30, around the age when the most pronounced behavioral deficits have been previously reported in juvenile fetal-alcohol subjects, no significant changes were found in either the hippocampal levels of synaptic proteins or in the spine density in principal hippocampal neurons.


Subject(s)
Central Nervous System Depressants/toxicity , Dendritic Spines/pathology , Ethanol/toxicity , Hippocampus/ultrastructure , Intracellular Signaling Peptides and Proteins/metabolism , Membrane Proteins/metabolism , Prenatal Exposure Delayed Effects/chemically induced , Prenatal Exposure Delayed Effects/pathology , Synaptophysin/metabolism , Age Factors , Analysis of Variance , Animals , Animals, Newborn , Central Nervous System Depressants/blood , Disks Large Homolog 4 Protein , Ethanol/blood , Female , Hippocampus/drug effects , Hippocampus/growth & development , Hippocampus/metabolism , Male , Pregnancy , Rats , Rats, Wistar , Silver Staining
9.
Alcohol ; 47(3): 173-9, 2013 May.
Article in English | MEDLINE | ID: mdl-23402901

ABSTRACT

Previous studies on the adverse effects of perinatal exposure to ethanol (EtOH) on the developing visual system mainly focused on retinal and optic nerve morphology. The aim of the present study was to investigate whether earlier reported retinal and optic nerve changes are accompanied by anomalies in eye-specific fiber segregation in the dorsal lateral geniculate nucleus (dLGN). C57BL/6 mice pups were exposed to ethanol by intragastric intubation at either 3 or 4 g/kg from postnatal days (PD) 3-10, the third trimester equivalent to human gestation. Control (C) and intubation control (IC) groups not exposed to ethanol were included. On PD9, retinogeniculate projections were labeled by intraocular microinjections of cholera toxin-ß (CTB) either conjugated to Alexa 488 (green) or 594 (red) administrated to the left and right eye, respectively. Pups were sacrificed 24 h after the last CTB injection. The results showed that ethanol exposure decreased the total number of dLGN neurons and significantly reduced the total dLGN projection as well as the contralateral and ipsilateral projection areas.


Subject(s)
Ethanol/toxicity , Geniculate Bodies/drug effects , Retina/drug effects , Visual Pathways/drug effects , Age Factors , Animals , Animals, Newborn , Female , Geniculate Bodies/growth & development , Geniculate Bodies/pathology , Male , Mice , Mice, Inbred C57BL , Random Allocation , Retina/growth & development , Retina/pathology , Visual Pathways/growth & development , Visual Pathways/pathology
10.
Alcohol Clin Exp Res ; 35(11): 2050-62, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21631543

ABSTRACT

BACKGROUND: The numerous adverse effects of ethanol abuse and ethanol withdrawal on biological systems are well documented. Conversely, the understanding of the molecular mechanisms underlying these pathological effects is still incomplete. This study was undertaken to investigate the effects of short-term chronic ethanol administration and ethanol withdrawal on the molecular structure and function of hippocampal tissue, a brain region important for mnemonic processes and known to be highly susceptible to ethanol intoxication. METHODS: Ethanol was administered to adult Wistar rats by intragastric intubation for 15 days with a stepwise increase in the daily dose from 6 to 12 g/kg body weight, with the highest dose delivered for the last 2 days only. The total daily dose of ethanol was divided into 3 equal portions administered 4 hours apart. Animals were sacrificed by decapitation at 4, 24, and 72 hours after the last ethanol administration to examine potential effects of ethanol intoxication and ethanol withdrawal. Ethanol-related molecular changes were monitored by Fourier transform infrared (FT-IR) spectroscopy. RESULTS: Significant changes in the hippocampal content, structure, and function of lipids, proteins, and nucleic acids were recorded under ethanol intoxication. Seventy-two hours after the cessation of ethanol administration, during the late phase of withdrawal, alterations in the macromolecules' content and conformational changes in protein and nucleic acid structure ameliorated, while the changes in macromolecular ratios, lipid order, and dynamics aggravated. CONCLUSIONS: Our results suggest that 15 days of binge-like drinking resulting in the high blood alcohol concentration (varying in the dose-dependent manner between 253 and 606 mg/dl) produced a strong physical dependence manifested mainly by the changes in lipid profiles pointing toward withdrawal-induced oxidative stress. These results show that ethanol withdrawal may cause equal to or even more severe brain damage than the ethanol itself, which should be considered when designing antialcohol therapies.


Subject(s)
Alcoholism/metabolism , Hippocampus/metabolism , Lipid Metabolism/physiology , Nucleic Acids/metabolism , Proteins/metabolism , Substance Withdrawal Syndrome/metabolism , Alcoholism/physiopathology , Animals , Behavior, Animal/drug effects , Behavior, Animal/physiology , Body Weight/drug effects , Body Weight/physiology , Disease Models, Animal , Ethanol/blood , Ethanol/pharmacology , Hippocampus/drug effects , Hippocampus/physiopathology , Male , Nucleic Acids/chemistry , Protein Structure, Secondary , Proteins/chemistry , Rats , Rats, Wistar , Spectroscopy, Fourier Transform Infrared , Substance Withdrawal Syndrome/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...